Tennessee Couple's Nightmare Vacation Turns into a Life-Saving Journey, Thanks to the SynCardia Total Artificial Heart
Jack Jones Got His 2nd Chance at Life Because of the World's First and Only FDA, Health Canada and CE (Europe) Approved Total Artificial Heart / http://www.syncardia.com
The husband, a farmer, and the wife, an accountant, were in Williamsburg, Va., July 21, 2013, on the first night of a road trip to celebrate their 25th wedding anniversary. That night Jack felt so uncomfortable he couldn't sleep. Over the last two years Jack had seen his regular doctor for a variety of complaints, including back, shoulder and chest pains, weakness, tiredness and night sweats. His physician told him he was fine and just getting older.
That July night, Mary drove Jack, 60, to a nearby hospital. Dropping him off at the emergency room (ER), Mary parked the car. Just as she was getting into the ER she was told that Jack had a heart attack and needed to immediately get to Sentara Heart Hospital 46 miles away. It floored her. "He went in walking and talking and he came out almost dead," she recalls.
Jack's regular doctor missed the signs of an earlier heart attack. With this second attack, Jack was suffering end-stage biventricular heart failure. Mary refused to be ushered into a waiting room as doctors at the hospital treated Jack with angioplasty and stents. An ambulance then rushed him to Sentara in Norfolk. The ambulance driver kept in close phone contact with Mary, who followed in her car, to assure her Jack was still alive.
Had the Joneses been at home in Tennessee, they would have had to drive at least two hours to get to a SynCardia Certified Center with cardiac surgeons specially trained to implant the SynCardia Heart. While there are 94 worldwide that are certified to implant the SynCardia Heart, none are in Tennessee.
Sentara's highly trained heart specialists first implanted a biventricular assist device (biVAD) to keep blood pumping while they assessed Jack's condition. It was clear his heart could no longer pump enough blood to sustain his life.
"They told me the heart muscle was gone," Mary says. Only the SynCardia temporary Total Artificial Heart, as a bridge to transplant, could keep him alive and help get him into better condition for a donor heart transplant. She quickly agreed to the implant. "It was not a decision. It was the only choice I had. I know Jack wants to live."
On July 24, while surgeons were preparing to implant the SynCardia Heart, Mary visited another SynCardia Heart patient in the hospital. "He was talking and laughing and eating," Mary says. "It gave me hope where I wasn't sure I had any more. I thought if I could get Jack to this point, I would be so happy."
He spent his first days with a SynCardia Heart attached to a driver the size of a washing machine that powers the heart with preciously calibrated pulses of air and small amounts of vacuum. Later he was fitted with the Freedom® portable driver, a 13.5-pound wearable power supply that gave Jack much more mobility and independence.
With the ability to move about, Jack exercised two days a week at the hospital's cardiac rehab facility. On his days off, he and Mary walked around the hospital, grounds, explored the outdoors and spent time playing with a therapy dog-also named Jack. "He was my little buddy," Jack says.
Mary quit her job to remain at Jack's side. They visited with staff and other patients and watched movies in his room, which they decorated for Halloween and Mary's birthday. "It helped with the healing process with her being there," says Jack.
Finally, the news they had been waiting for arrived: Jack would get his donor heart transplant. Jack the therapy dog sat on Jack's lap as he rode in a wheelchair to the operating room. "Jack helped me stay calm and ready for my transplant," he says.
"The Total Artificial Heart did everything the doctors said it would do," says Mary. "And the Freedom driver let Jack do rehab before the transplant, so he did better with the transplant than he would have without the Freedom driver."
"I have different priorities now," says Jack. "I want to take some time to enjoy life."
Jack left the hospital Dec. 13. Today he feels he's improving every day. The couple plans to take the same trip they had started last summer. This time they're calling it their celebration of life.
CAUTION - The Freedom portable driver is an investigational device, limited by United States law to investigational use.
- See Jack Jones as he prepares to leave Sentara Heart Hospital with a new heart.
- Read news coverage of Jack Jones's journey from near death to health with the SynCardia Total Artificial Heart.
SynCardia Systems Inc
SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the SynCardia Total Artificial Heart is currently approved as a bridge to transplant for people suffering from end stage heart failure affecting both sides of the heart (biventricular failure). There have been more than 1,260 implants of the Total Artificial Heart, accounting for more than 350 patient years of life on the device.
Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves. It is the only device that eliminates the symptoms and source of end stage biventricular failure. Unlike a donor heart, the Total Artificial Heart is immediately available at 94 SynCardia Certified Centers worldwide with 37 others in the process of certification.
The Total Artificial Heart provides immediate, safe blood flow of up to 9.5 liters per minute through each ventricle. This high volume of blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.
Forbes Ranks SynCardia #69 Among "America's Most Promising Companies"
In its February 2013 issue, Forbes selected SynCardia as one of "America's Most Promising Companies" for the second consecutive year. On the list of 100 privately held, high-growth companies with bright futures, SynCardia was selected #69, moving up eight spots from its #77 ranking last year. See the full list of SynCardia Awards & Recognition.
For additional information, please visit: http://www.syncardia.com
Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkdIn
Press releases you might also be interested in
Weitere Informationen zum Thema "Medizintechnik":
Mehr Transparenz bei Künstlicher Intelligenz
Künstliche Intelligenz (KI), englisch Artificial Intelligence (AI), hat bisher ein Transparenzproblem: Läuft der AI-Service überhaupt? Was macht der AI-Service? Worauf greift er zu? Spezielle Monitoring-Dienste helfen bei der Überwachung Künstlicher Intelligenz.Weiterlesen